BIOLOGY BULLETIN

投稿咨询

官方网站：http://www.springer.com/life+sciences/journal/10525

投稿网址：https://www.springer.com/life+sciences/journal/10525

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1062-3590%5BISSN%5D

《生物学公报》是一本跨学科的国际同行评议期刊，涵盖生物学的所有主题。主要从事细胞生物学、生物化学、动物学、植物学、生理学、生态学等领域的基础研究。该杂志发表实验研究和评论文章的当前生物学问题。同行评审《生物学公报》是一份同行评议的期刊。我们使用单一的盲同行评审格式。我们的审稿人团队包括超过100名审稿人，包括内部审稿人和外部审稿人(80%)。2017年从提交到首次评审的平均周期为7天，从首次评审到验收的平均周期为30天。2017年投稿退稿率为18%。接受发表文章的最终决定由编辑委员会作出。被邀请的审稿人因利益冲突，认为不符合审稿条件或者不能审稿的，应当及时通知审稿人，并予以拒绝。审稿人应以一种合理合理的方式清晰地阐述自己的观点，这样作者才能利用审稿人的观点来完善稿件。必须避免对作者的个人批评。评论者应该显示发表的一篇评论(我)任何相关的工作没有被引用的作者,(2)任何已报道在以前的出版物和没有适当的参考或引用,(2)任何实质性相似或重叠与其他手稿(发表或未发表)的个人知识。

Biology Bulletin is an interdisciplinary international peer reviewed journal on all topics of biology. It focuses on fundamental studies in the fields of cell biology, biochemistry, zoology, botany, physiology, and ecology. This journal publishes experimental studies and reviews articles on current problems in biology.PEER REVIEWBiology Bulletin is a peer reviewed journal. We use a single blind peer review format. Our team of reviewers includes over 100 reviewers, both internal and external (80%). The average period from submission to first decision in 2017 was 7 days, and that from first decision to acceptance was 30 days. The rejection rate for submitted manuscripts in 2017 was 18%. The final decision on the acceptance of an article for publication is made by the Editorial Board.Any invited reviewer who feels unqualified or unable to review the manuscript due to the conflict of interests should promptly notify the editors and decline the invitation. Reviewers should formulate their statements clearly in a sound and reasoned way so that authors can use reviewer’s arguments to improve the manuscript. Personal criticism of the authors must be avoided. Reviewers should indicate in a review (i) any relevant published work that has not been cited by the authors, (ii) anything that has been reported in previous publications and not given appropriate reference or citation, (ii) any substantial similarity or overlap with any other manuscript (published or unpublished) of which they have personal knowledge.